#13735 on the rich list of 14,644 insiders
Patrick D. Yeramian
Chief Medical Officer at Amylyx Pharmaceuticals. Based in Cambridge, Massachusetts.
$5.4M
in disclosed stock, −$86K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 13735th of 14,644
- Companies held
- 1
- Largest holding
- AMLX, 100.0% of total
- Latest SEC filing
- Jan 9, 2024
What the $5.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals AMLX Common Stock | Directly | 205,605 | $26.20 | $5.4M | 100.0% | Form 4, Jan 9, 2024 |
Share counts are the amounts Patrick D. Yeramian reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13732 | Stewart Ellis Director, Hippo Holdings. San Jose, CA | $5.4M |
| 13733 | Anastasis Nikolaou 10% owner, Acrivon Therapeutics | $5.4M |
| 13734 | Wiaczeslaw Smolokowski 10% owner, Acrivon Therapeutics | $5.4M |
| 13735 | Patrick D. Yeramian Chief Medical Officer, Amylyx Pharmaceuticals. Cambridge, MA | $5.4M |
| 13736 | Seth Gersch Director, Global Indemnity Group, LLC. Wilmington, DE | $5.4M |
| 13737 | David Lawrence Churchill CHIEF TECHNOLOGY OFFICER, BETA Technologies. South Burlington, VT | $5.4M |
| 13738 | Jimmy R. Scripps 10% owner, The E.W. Scripps. Ft. Mitchell, KY | $5.4M |
Other Amylyx Pharmaceuticals insiders
All AMLX insiders- Joshua B. Cohen$92.0MCo-Chief Executive Officer. #1600 overall
- Justin B. Klee$92.0MCo-Chief Executive Officer. #1601 overall
- George M. Milne Jr.$20.5MDirector. #4876 overall
- James M. Frates$10.1MChief Financial Officer. #8733 overall
- Camille L. Bedrosian$7.3MChief Medical Officer. #9587 overall
- Margaret Olinger$7.2MChief Commercial Officer. #11149 overall
Questions
How much stock does Patrick D. Yeramian own?
Patrick D. Yeramian holds $5,386,851 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 13735th on the Stock Rich List.
Is this Patrick D. Yeramian's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.